The new Glaxo Wellcome nucleoside, compassionate use program for adults, pediatrics, and CNS has announced an 800 number for doctors to call for the open label program. This program is limited in size and criteria for entry. Interested parties should have their physician contact the coordinating center at --
1 800 501 4672
A larger and broader expanded access program is planned for early in 1998.
On this website is an article on 1592U89 cross-resistance which is recommended reading prior to enrollment in the compassionate access program. The article is titled --
"1592U89: Cross-Resistance With Nucleosides and Expanded Access; CNS Penetration in Animals."